Micronized Purified Flavonoid Fraction

DRUG3 trials

Sponsors

Sir Mortimer B. Davis - Jewish General Hospital, Belarusian State Medical University, Pirogov Russian National Research Medical University

Conditions

Pelvic Venous DisordersPost-Thrombotic SyndromeSurgeryVaricose Veins

Phase 3

The MUFFIN-PTS Trial

Sir Mortimer B. Davis - Jewish General HospitalPost-Thrombotic Syndrome

Start: 2022-02-04End: 2024-05-30Updated: 2023-11-30

Venoactive Drug Treatment of Pelvic Venous Disorders

RecruitingNCT06584799

Pirogov Russian National Research Medical UniversityPelvic Venous Disorders

Start: 2024-12-31End: 2025-02-28Target: 150Updated: 2024-12-27

Unknown Phase

MIcronized Flavonoid Fraction After MechanO-Chemical Ablation

Belarusian State Medical UniversitySurgery, Varicose Veins

Start: 2019-01-01End: 2022-12-31Target: 100Updated: 2021-11-16

Related Papers

Venoactive drug treatment for patients with pelvic varicose veins: Results of the single-center, randomized, open-label study (VENOTREAT)

Vascular Medicine2025-08-251 citations

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

BMJ Open2021-09-019 citations